Elevai Labs, Inc. - Common StockShare · US28622K1043 · ELAB (XNAS) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Elevai Labs, Inc. - Common Stock
No Price
01.05.2026 23:48
Current Prices from Elevai Labs, Inc. - Common Stock
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
NASDAQ
ELAB
USD
01.05.2026 23:48
2,47 USD
0,009 USD
+0,37 %
IEX
ELAB
USD
01.05.2026 19:59
2,51 USD
0,05 USD
+2,03 %
Share Float & Liquidity
Free Float99,83 %
Shares Float1,93 M
Shares Outstanding1,94 M
Company Profile for Elevai Labs, Inc. - Common Stock Share
PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of cutting-edge aesthetic medicines and therapeutic products. The company's lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. It is also involved in the medical scientific research and development activities, as well as operates investment firms. The company was formerly known as Elevai Labs, Inc. and changed its name to PMGC Holdings Inc. in December 2024. PMGC Holdings Inc. was incorporated in 2020 and is based in Newport Beach, California.
